TABLE 2.

Outcomes of clinical pharmacy services for TB care management by intervention focus.

Intervention focus	Outcome
Drug selection	Pharmaceutical intervention acceptance rate (Abrogoua et al., 2016)
HRQoL	EQ-5D-3L score (Tanvejsilp et al., 2018)
	VAS (Tanvejsilp et al., 2018)
Medication/therapy effectiveness	Cure (Tang et al., 2018; Tanvejsilp et al., 2018)
	Death (Tang et al., 2018; Tanvejsilp et al., 2018)
	Default (Tang et al., 2018; Tanvejsilp et al., 2018)
	Failure (Tang et al., 2018)
	Not completed (Tanvejsilp et al., 2018)
	Transfer out (Tang et al., 2018)
	Treatment completion (Tang et al., 2018; Tanvejsilp et al., 2018)
	Treatment success (Tang et al., 2018)
	Sputum conversion (%) (Venkatapraveen et al., 2012)
	Sputum conversion time (months) (Tang et al., 2018)
Medication adherence	Adherence level (Karuniawati et al., 2019)
	Attendance (Clark et al., 2007; Tang et al., 2018)
	Compliance (Karuniawati et al., 2019)
	Isoniazid metabolites (Clark et al., 2007; Tang et al., 2018)
	Medication counting (Clark et al., 2007; Tang et al., 2018)
	Morisky Adherence Questionnaire Scale (Bhardwaja et al., 2012; Thomas et al., 2018)
Medication safety	Pharmaceutical care impact index (Lopes et al., 2017)
	Pharmaceutical care needs (Clark et al., 2007; Tang et al., 2018)
	Pharmaceutical intervention acceptance rate (Abrogoua et al., 2016)
Patient/caregiver educational needs/beliefs	Adherence barrier: knowledge (Thomas et al., 2018)
	Adherence barrier: personal (Thomas et al., 2018)
	Adherence barrier: psychological (Thomas et al., 2018)
	Knowledge (Thomas et al., 2018; Narayana et al., 2020)
	Knowledge and adherence score (Venkatapraveen et al., 2012)
	Medication adherence (Narayana et al., 2020)

HRQoL, health-related quality of life; EQ-5D-3L, Euro Quality of Life 5 Dimensions 3 Levels; VAS, visual analog scale.